Sun Pharmaceutical Industries (NSE: SUNPHARMA) reported its third-quarter 2022 earnings results today.
The company reported consolidated revenue of ₹10,295 crores with a growth of 12% year on year.
Sun Pharma had a total net profit of ₹206 crores or ₹8.6 per share compared to ₹1852 crores ₹7.7 per share in the same quarter of the previous year.